Barclays Lowers Molina Healthcare (NYSE:MOH) Price Target to $430.00

Molina Healthcare (NYSE:MOH) had its price target reduced by analysts at Barclays from $437.00 to $430.00 in a research note issued on Thursday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Barclays‘s price target would indicate a potential upside of 25.65% from the company’s previous close.

MOH has been the subject of several other research reports. Bank of America cut shares of Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 target price for the company. in a report on Thursday, March 28th. Truist Financial increased their target price on shares of Molina Healthcare from $435.00 to $460.00 and gave the stock a “buy” rating in a report on Tuesday, February 20th. Wells Fargo & Company reduced their target price on shares of Molina Healthcare from $440.00 to $410.00 and set an “equal weight” rating for the company in a report on Monday, April 15th. StockNews.com cut shares of Molina Healthcare from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 8th. Finally, Stephens restated an “equal weight” rating and set a $390.00 target price on shares of Molina Healthcare in a report on Thursday. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $396.09.

Molina Healthcare Stock Down 2.9 %

Shares of MOH stock opened at $342.23 on Thursday. The firm has a fifty day moving average of $391.53 and a 200-day moving average of $371.87. The company has a quick ratio of 1.54, a current ratio of 1.49 and a debt-to-equity ratio of 0.53. Molina Healthcare has a 12-month low of $266.35 and a 12-month high of $423.92. The company has a market capitalization of $20.05 billion, a price-to-earnings ratio of 18.57, a P/E/G ratio of 0.99 and a beta of 0.47.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, April 24th. The company reported $5.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.46 by $0.27. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. The company had revenue of $9.93 billion during the quarter, compared to the consensus estimate of $9.45 billion. During the same quarter in the prior year, the firm earned $5.81 earnings per share. The firm’s revenue was up 21.9% compared to the same quarter last year. As a group, equities research analysts predict that Molina Healthcare will post 23.62 earnings per share for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, CFO Mark Lowell Keim sold 15,000 shares of the stock in a transaction on Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the sale, the chief financial officer now owns 36,531 shares in the company, valued at $14,121,423.36. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, CFO Mark Lowell Keim sold 15,000 shares of the firm’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the completion of the sale, the chief financial officer now owns 36,531 shares in the company, valued at approximately $14,121,423.36. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Richard M. Schapiro sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total transaction of $401,050.00. Following the sale, the director now owns 11,207 shares of the company’s stock, valued at approximately $4,494,567.35. The disclosure for this sale can be found here. Insiders sold a total of 16,711 shares of company stock worth $6,472,517 over the last quarter. 1.10% of the stock is currently owned by insiders.

Institutional Trading of Molina Healthcare

A number of hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. increased its position in Molina Healthcare by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 6,585,954 shares of the company’s stock worth $2,379,571,000 after acquiring an additional 23,715 shares during the period. Capital World Investors increased its position in Molina Healthcare by 0.3% during the fourth quarter. Capital World Investors now owns 5,490,147 shares of the company’s stock worth $1,983,645,000 after acquiring an additional 14,775 shares during the period. Wellington Management Group LLP increased its position in Molina Healthcare by 12.8% during the fourth quarter. Wellington Management Group LLP now owns 3,831,100 shares of the company’s stock worth $1,384,215,000 after acquiring an additional 436,060 shares during the period. Capital Research Global Investors increased its position in Molina Healthcare by 5.4% during the fourth quarter. Capital Research Global Investors now owns 2,430,283 shares of the company’s stock worth $878,086,000 after acquiring an additional 123,894 shares during the period. Finally, FMR LLC increased its position in Molina Healthcare by 1.0% during the third quarter. FMR LLC now owns 2,175,796 shares of the company’s stock worth $713,422,000 after acquiring an additional 22,583 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.